Civica Rx Celebrates Its First Birthday!

Overheard at a recent Congressional Hearing on the reliability of the global generic drug supply chain: “I think it is fascinating to watch what the private sector hospitals in the United States are doing…they formed a nonprofit called Civica Rx in response to persistent shortages of vital life-saving medicines…and they are doing direct contracting with trustworthy manufacturers…with...

Vizient Announces It Will Help Civica Reduce Drug Shortages

Vizient, based in Irving Texas, will provide insights into purchasing patterns and provider needs through their analytics and data capabilities, helping Civica anticipate gaps in drug availability and affordability. “We applaud Vizient for helping to find innovative ways to reduce drug shortages through their analytics and data expertise,” said Martin VanTrieste, Civica CEO.  “The...

Civica Rx and Xellia Pharmaceuticals Join Forces

Civica Rx announces its first supplier partner, Xellia Pharmaceuticals. Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin, for Civica’s member health systems to address shortages of these anti-infective medications and improve patient care in hospitals across the US. Today marks the first time that Civica is announcing the production of generic drugs –...

Recent Recognition

The Medicine Maker selects Martin VanTrieste, Civica CEO, for its 2019 Power List, naming him as one of the Champions of Change. "I am honored and deeply humbled to be named to The Medicine Maker 2019 Power List, Champions of Change. The credit goes to the entire Civica team for their hard work and...

Scroll to top